{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:17:42Z","timestamp":1761895062448,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.3816\/clml.2010.n.021","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T02:43:39Z","timestamp":1270608219000},"page":"144-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review"],"prefix":"10.3816","volume":"10","author":[{"given":"Mark G.","family":"Ochenrider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Aboulafia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLML.2010.n.021_bib1","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"10.3816\/CLML.2010.n.021_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00000478-200007000-00016","article-title":"Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma","volume":"24","author":"Suarez","year":"2000","journal-title":"Am J Surg Pathol"},{"year":"2001","series-title":"World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","key":"10.3816\/CLML.2010.n.021_bib3"},{"key":"10.3816\/CLML.2010.n.021_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","article-title":"Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?","volume":"13","author":"Rosh","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"suppl 1","key":"10.3816\/CLML.2010.n.021_bib5","first-page":"A1020","article-title":"Intravenous cyclosporine for refractory attacks of Crohn's disease (CD): long-term follow up of patients","volume":"114","author":"L\u00e9mann","year":"1998","journal-title":"Gastroenterology"},{"key":"10.3816\/CLML.2010.n.021_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1042819021000035662","article-title":"Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine","volume":"44","author":"Navarro","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLML.2010.n.021_bib7","first-page":"220","article-title":"Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease","volume":"40","author":"Thayu","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.3816\/CLML.2010.n.021_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","article-title":"A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab","volume":"76","author":"Mittal","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLML.2010.n.021_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.3816\/CLML.2010.n.021_bib10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/10428190701345433","article-title":"Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy","volume":"48","author":"Zeidan","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLML.2010.n.021_bib11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/gut.2008.163279","article-title":"Hepatosplenic T cell lymphoma in inflammatory bowel disease","volume":"57","author":"Shale","year":"2008","journal-title":"Gut"},{"key":"10.3816\/CLML.2010.n.021_bib12","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLML.2010.n.021_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5694\/j.1326-5377.2008.tb02124.x","article-title":"Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease","volume":"189","author":"Drini","year":"2008","journal-title":"Med J Aust"},{"key":"10.3816\/CLML.2010.n.021_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/10428190802087488","article-title":"Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha","volume":"49","author":"Humphreys","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLML.2010.n.021_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e3181957a11","article-title":"Hepatosplenic T-cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update","volume":"48","author":"Mackey","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"suppl 1","key":"10.3816\/CLML.2010.n.021_bib16","first-page":"A116","article-title":"818 Excess risk of lymphoproliferative disorders (LPD) in inflammatory bowel diseases (IBD): interim results of the Cesame cohort","volume":"134","author":"Beaugerie","year":"2008","journal-title":"Gastroenterology"},{"key":"10.3816\/CLML.2010.n.021_bib17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/gut.2009.181982","article-title":"Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle","volume":"58","author":"Sokol","year":"2009","journal-title":"Gut"},{"key":"10.3816\/CLML.2010.n.021_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.21062","article-title":"Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen","volume":"83","author":"Tey","year":"2008","journal-title":"Am J Hematol"},{"key":"10.3816\/CLML.2010.n.021_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00000478-199707000-00006","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q","volume":"21","author":"Fran\u00e7ois","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLML.2010.n.021_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.3816\/CLML.2010.n.021_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","article-title":"Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas","volume":"64","author":"Geborek","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.3816\/CLML.2010.n.021_bib22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.3816\/CLML.2010.n.021_bib23","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.3816\/CLML.2010.n.021_bib24","unstructured":"Centocor Ortho Biotech Inc. New one-year data from REMICADE\u00ae SONIC trial show sustained efficacy compared with azathioprine in treatment of Crohn's disease [Web site]. Medical News Today; 2009 Accessed: February 9, 2010. Available at: www.medicalnewstoday.com\/articles\/152322.php."}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501170101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501170101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:23:37Z","timestamp":1761870217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226501170101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S215226501170101X"],"URL":"https:\/\/doi.org\/10.3816\/clml.2010.n.021","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLML.2010.n.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}